NCT03789734View on ClinicalTrials.gov

Safety Study of BLS-M22 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

June 4, 2019

Primary Completion Date

April 23, 2020

Study Completion Date

November 27, 2020

Conditions
Muscular Dystrophy, Duchenne
Interventions
BIOLOGICAL

BLS-M22

BLS-M22 250mg/capsule

OTHER

Placebo

BLS-M22 placebo 250mg/capsule

Trial Locations (1)

Unknown

BioLeaders Co., Ltd., Gyeonggi-do

Sponsors
All Listed Sponsors
lead

BioLeaders Corporation

INDUSTRY

NCT03789734 - Safety Study of BLS-M22 in Healthy Volunteers | Biotech Hunter | Biotech Hunter